Friday, October 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

IBM’s Earnings Face Dual Test: AI Anxiety and Integration Costs

Rodolfo Hanigan by Rodolfo Hanigan
April 22, 2026
in AI & Quantum Computing, Dow Jones, Earnings, Tech & Software
0
IBM Stock
0
SHARES
55
VIEWS
Share on FacebookShare on Twitter

As IBM prepares to release its first-quarter 2026 results after the US market close today, the technology giant finds itself at a crossroads. Investors are weighing two powerful, opposing forces: the promise of growth from its software and infrastructure units against significant threats to its legacy consulting business and the immediate costs of a major acquisition.

The market’s nervousness is palpable in the stock’s performance. Trading recently at 218.80 euros, IBM shares have fallen roughly 13% since the start of the year. A single-day plunge of 13% in late February marked the stock’s worst daily drop in nearly a quarter-century. That sell-off was triggered by AI startup Anthropic, which claimed its new tool could modernize outdated COBOL code—a direct challenge to IBM’s lucrative mainframe ecosystem where such legacy applications are common.

Software Strength and Acquisition Impact

Wall Street expects the company to report robust headline figures for Q1. Consensus estimates point to revenue of $15.6 billion and earnings per share of $1.81, a solid increase from the $1.60 reported a year earlier. The software division, bolstered by Red Hat and the recent acquisition of data-streaming platform Confluent, is seen as the primary growth engine. Analyst Brent Thill of Jefferies views IBM as an undervalued AI beneficiary and anticipates software performance exceeding market expectations.

The Confluent deal, finalized in March, is a key focal point. Bank of America analyst Wamsi Mohan projects it will contribute approximately $50 million in revenue. However, the early closing brings near-term financial headwinds. Analysts have subsequently trimmed their full-year 2026 EPS estimates to $11.98, citing dilution from the acquisition and ongoing softness in consulting.

Consulting Weakness and Infrastructure Support

Should investors sell immediately? Or is it worth buying IBM?

The consulting segment remains a sore spot, having grown by just 1% in the final quarter of 2025. The rise of AI-powered programming tools poses a growing threat to this labor-intensive core service. While IBM management has pushed back against Anthropic’s claims—arguing that code translation is the easy part compared to data architecture redesign and hardware integration—investor concern persists.

Offsetting this weakness, the infrastructure business is forecast to be a pillar of strength. Bank of America predicts roughly 24% revenue growth for the division, driven by the new z17 mainframe cycle. This hardware resilience is critical as the company seeks to prove that demand for its AI platform, watsonx, can counterbalance traditional consulting challenges.

Dividend Tradition and Cash Flow

Income-focused investors await news on IBM’s legendary dividend. The company has paid consecutive dividends since 1916 and raised them annually for over three decades. Analysts anticipate an increase in the quarterly payout to about $1.69 per share, a move supported by strong cash generation. IBM generated substantial free cash flow last year and is targeting approximately $15.7 billion for 2026.

The analyst community maintains a cautiously optimistic stance, though several firms have recently lowered price targets while reaffirming buy ratings:
– Jefferies: “Buy,” target reduced from $370 to $320
– RBC Capital: “Outperform,” target cut from $361 to $330
– Oppenheimer: “Outperform,” target lowered from $380 to $320
– Stifel: “Buy,” target adjusted down from $340 to $290

Today’s report serves as the first major test of management’s forecast for mid-single-digit currency-adjusted revenue growth in 2026. Concrete commentary on AI monetization and the consulting division’s trajectory will likely set the stock’s near-term direction.

Ad

IBM Stock: Buy or Sell?! New IBM Analysis from October 23 delivers the answer:

The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 23.

IBM: Buy or sell? Read more here...

Tags: IBM
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Apple Stock

Apple's Leadership Handover Coincides with Upcoming Earnings Test

Adobe Stock

Adobe's AI Ecosystem Bet Aims to Reassure a Wary Market

ImmunityBio Stock

ImmunityBio's Legal and Financial Trajectories Diverge Sharply

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com